Stock Quote
CVS Caremark Corporation (CVS) (NYSE Arca)
sector: Non-Cyclical Consumer Goods & Services .
industry: Retail - Drugs ·
View CVS on other exchanges
$31.89
4:01pm EST
+0.79%
$31.64
$31.91
19,636,358
$32.27
$31.10
$38.27
$23.74
0.72
23,834,714
CVS
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Ryan, Thomas | Chairman of the Board, President, CEO; Interim President of Caremark Pharmacy Services | 24,102,648 |
| Denton, David | Chief Financial Officer, Executive Vice President | -- |
| Phillips, Chip | President of TheraCom | -- |
Profile
CVS Caremark Corporation (CVS Caremark) is a provider of prescriptions and related healthcare services in the United States. It is a pharmacy services company and drives value for its customers through its approximately 6,900 CVS/pharmacy and Longs Drug retail stores; CVS Caremark’s pharmacy benefit... Full Description
Company Address
CVS Caremark Corporation
One CVS Drive
Woonsocket RI 02895
P: +1401.7651500
F: +1401.7622137
One CVS Drive
Woonsocket RI 02895
P: +1401.7651500
F: +1401.7622137
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Medco Health Solutions Inc. | $62.70 | +1.09 |
| Express Scripts, Inc. | $87.95 | +2.86 |
| UnitedHealth Group Inc. | $29.08 | +0.52 |
| CVS | Industry | |
|---|---|---|
| P/E(TTM) | 12.82 | 2.54 |
| P/S(TTM) | 0.46 | 0.07 |
| ROI(TTM) | 7.58 | 1.33 |
| ROE(TTM) | 10.42 | 2.03 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 0.60 |
| EPS Est. (Current Year) | 2.62 |
| Total Revenue | $24,641.90M |
| Net Income | $1,023.10M |
| EPS | $0.71 |
